Recurrent CDK1 overexpression in laryngeal squamous cell carcinoma

Area of Science:

• Molecular Oncology
• Gene Expression Analysis
• Carcinogenesis Research

Background:

• Laryngeal squamous cell carcinoma (LSCC) is a significant head and neck cancer.
• Dysregulation of cell cycle genes is implicated in cancer development.
• CDK1 (Cyclin-dependent kinase 1) plays a crucial role in cell cycle regulation and has oncogenic potential.

Purpose of the Study:

• To analyze the expression profile of cell cycle-related genes (CCNA2, CCNB1, CCNB2, CDK1) in LSCC.
• To investigate the potential genetic and epigenetic mechanisms responsible for CDK1 overexpression in LSCC.

Main Methods:

• Microarray analysis for gene expression profiling.
• Reverse transcription quantitative polymerase chain reaction (RT-qPCR), Western blot, and immunohistochemistry (IHC) for CDK1 validation.
• Array-comparative genomic hybridization (aCGH), DNA sequencing, pyrosequencing for DNA methylation, and miRNA expression analysis.

Main Results:

• Overexpression of CCNA2, CCNB1, CCNB2, and CDK1 was observed in LSCC samples compared to non-cancer controls.
• CDK1 upregulation was confirmed at mRNA and protein levels using multiple techniques.
• No significant alterations in DNA sequence, copy number, DNA methylation, or miRNA expression were found to explain CDK1 upregulation.

Conclusions:

• CDK1 is significantly upregulated in laryngeal squamous cell carcinoma.
• The study failed to identify common genetic or epigenetic mechanisms driving CDK1 overexpression in LSCC.
• Altered CDK1 expression likely occurs at an early stage of laryngeal carcinogenesis.